Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Janus International
JBI
$732M
| $11.9M | ﹤0.01% |
1,460,382
+147,005
| +11% | +$1.12M |
|
|
GOLD
1927
Gold.com Inc
GOLD
$1.18B
| $11.9M | ﹤0.01% |
535,578
+205,433
| +62% | +$4.56M |
|
1928
Dime Commercial Bancshares
DCOM
$1.8B
| $11.9M | ﹤0.01% |
440,000
+44,471
| +11% | +$1.16M |
|
1929
American Superconductor
AMSC
$1.39B
| $11.8M | ﹤0.01% |
322,958
+13,277
| +4% | +$326K |
|
1930
Vita Coco
COCO
$3.97B
| $11.8M | ﹤0.01% |
327,618
+7,335
| +2% | +$245K |
|
|
STEL
1931
DELISTED
Stellar Bancorp
STEL
| $11.8M | ﹤0.01% |
421,268
-15,550
| -4% | -$413K |
|
|
VTLE
1932
DELISTED
Vital Energy
VTLE
| $11.8M | ﹤0.01% |
730,939
+142,266
| +24% | +$2.33M |
|
1933
Full Truck Alliance
YMM
$9.64B
| $11.7M | ﹤0.01% |
994,544
+87,057
| +10% | +$1.01M |
|
1934
CG Oncology
CGON
$6.41B
| $11.7M | ﹤0.01% |
450,296
+11,018
| +3% | +$266K |
|
1935
Compass Minerals
CMP
$1.25B
| $11.7M | ﹤0.01% |
580,297
+92,360
| +19% | +$1.49M |
|
1936
Marcus & Millichap
MMI
$1.2B
| $11.6M | ﹤0.01% |
378,242
-28,895
| -7% | -$877K |
|
|
NXRT
1937
NexPoint Residential Trust
NXRT
$686M
| $11.6M | ﹤0.01% |
348,572
-12,307
| -3% | -$436K |
|
1938
SunCoke Energy
SXC
$779M
| $11.6M | ﹤0.01% |
1,351,987
+197,288
| +17% | +$1.71M |
|
1939
Apogee Therapeutics
APGE
$10.1B
| $11.6M | ﹤0.01% |
266,384
-5,495
| -2% | -$209K |
|
1940
OceanFirst Financial
OCFC
$1.74B
| $11.6M | ﹤0.01% |
656,833
+24,647
| +4% | +$411K |
|
|
INN
1941
Summit Hotel Properties
INN
$743M
| $11.5M | ﹤0.01% |
2,264,773
+416,293
| +23% | +$1.83M |
|
1942
Garrett Motion
GTX
$5.6B
| $11.5M | ﹤0.01% |
1,096,422
+265,806
| +32% | +$2.68M |
|
1943
Sarepta Therapeutics
SRPT
$1.63B
| $11.5M | ﹤0.01% |
673,877
+27,586
| +4% | +$1.18M |
|
1944
Tencent Music
TME
$15.6B
| $11.5M | ﹤0.01% |
591,196
-276,931
| -32% | -$4.35M |
|
1945
Expro Ltd
XPRO
$1.75B
| $11.5M | ﹤0.01% |
1,340,531
+100,574
| +8% | +$853K |
|
1946
Tandem Diabetes Care
TNDM
$1.22B
| $11.5M | ﹤0.01% |
617,000
+46,850
| +8% | +$928K |
|
1947
Orion
OEC
$400M
| $11.4M | ﹤0.01% |
1,090,687
+60,820
| +6% | +$688K |
|
1948
Agilon Health
AGL
$1.65B
| $11.4M | ﹤0.01% |
198,836
+1,253
| +0.6% | +$100K |
|
1949
Collegium Pharmaceutical
COLL
$1.16B
| $11.4M | ﹤0.01% |
386,100
+30,841
| +9% | +$880K |
|
1950
Travere Therapeutics
TVTX
$5.2B
| $11.4M | ﹤0.01% |
771,296
+86,753
| +13% | +$1.44M |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.